Casi Pharmaceuticals Inc Expected To Post A Loss Of 6 Cents A Share: Earnings Preview

CASI Pharmaceuticals

11/05/2021 16:50

* CASI Pharmaceuticals Inc  CASI.OQ   CASI.O  is expected
to show a rise in quarterly revenue when it reports results on
May 13 .
* The Rockville, Maryland-based company is expected to report 
 a 48.3% increase in revenue to $5.05 million from $3.41 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for CASI Pharmaceuticals
Inc is for a loss of 6 cents per share. For the same quarter
last year, the company reported a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $3.8​, about 61.8% above​ its last
closing price of $1.45. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020              -0.07      -0.12     Missed  -71.4
 Sep. 30 2020  -0.06       -0.05      -0.14     Missed  -154.5
 Jun. 30 2020  -0.08       -0.08      -0.07     Beat    12.5​
 Mar. 31 2020              -0.11      -0.09     Beat    18.2
 Dec.          ​           -0.11      -0.12     Missed  -9.1​
 31​ 2019​                                              
 Sep. 30 2019  -0.11       -0.11      -0.10     Beat    9.1​
 Jun. 30 2019  -0.09       -0.09      -0.16     Missed  -77.8
 Mar. 31 2019  -0.09       -0.09      -0.09     Met     0
 This summary was machine generated May 11 at 15:50 GMT.  All
figures in US dollars unless otherwise stated